Genex Pharmaceutical, Inc. Stock price

Equities

GENX

US37227T1051

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 11:14:08 2023-09-15 am EDT 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Genex Pharmaceutical, Inc. -.--% -.--%
Sales 2006 2.44M Sales 2007 3.24M Capitalization 5.18M
Net income 2006 - Net income 2007 - EV / Sales 2006 0.95 x
Net cash position 2006 0.19 Net Debt 2007 0.14 EV / Sales 2007 1.6 x
P/E ratio 2006
3.75 x
P/E ratio 2007
15.1 x
Employees 86
Yield 2006 *
-
Yield 2007
-
Free-Float 99.62%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0
0.03
5 years
0.00
Extreme 0
0.04
10 years
0.00
Extreme 0
0.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 04-06-16
Director of Finance/CFO 70 04-06-16
Members of the board TitleAgeSince
Chief Executive Officer 70 04-06-16
More insiders
Genex Pharmaceutical, Inc. (Genex) was considered a development-stage company prior to June 17, 2004. Genex was a start-up, Internet-based fulfillment company with offices in Vancouver, British Columbia, Canada. On June 8, 2004, Genex entered into a share purchase agreement with Tianjin Zhongjin Biology Development Co., Ltd. (Zhongjin). On June 17, 2004, the stock purchase made pursuant to the share purchase agreement was consummated and Zhongjin became a wholly owned subsidiary of Genex. Zhongjin engages in the business of producing and distributing Reconstituted Bone Xenograft (RBX), which is considered a medical device that accelerates bone healing. Zhongjin solely markets its medical devices to hospitals in China. Zhongjin distributes its medical devices to more than 500 hospitals in 30 provinces throughout China. Zhongjin also markets its medical devices to medical device customers in China that are not hospitals.
More about the company
  1. Stock
  2. Equities
  3. Stock Genex Pharmaceutical, Inc. - OTC Markets